Pharmacy Report Archives - Page 15 of 150 - Becker's Hospital Review

Geisinger CPO: $1M+ drugs need new payment models | FDA adds brain tumor warning to Pfizer drug | 5 headwinds ahead | Conn. hospital debuts specialty pharmacy | CDC adopts new hep B guidance

New drug payment ideas, FDA safety warnings & 5 headwinds ahead. December 17, 2025 1. A payer-provider view on ultra high-cost drugs Full story 2. FDA adds brain tumor warning to Depo-Provera label Full story 3. Critical access hospitals: What…

Pharma execs map 6 focuses for 2026 | FDA taps cancer drug for priority voucher program | An 'essential' pharmacy shift | Xofluza outperforms Tamiflu in study | How payers are 'embracing AI'

Pharmacy execs map 2026 strategy as FDA expands priority voucher use. December 16, 2025 1. What pharmacy leaders are scaling in 2026 Full story 2. FDA taps J&J drug for priority voucher program Full story 3. Specialty drug spend ballooning?…

Top 10 drugs driving 340B spending | CVS settles underpayment claims in Okla. | Sanofi's MS drug faces setbacks | 5 trends shaping pharma strategy | FDA weighs black box warning for COVID shots

340B drug spending, a CVS Caremark settlement & hospitals' 2026 pharma strategy lead today's news December 15, 2025 1. CVS Caremark settles pharmacy underpayment allegations for $5M Full story 2. Top 10 340B drugs in 2024: Report Full story 3.…

FDA eyes vaccine approval overhaul | Pharmacy agency recognizes 16th specialty | 10 systems seeking pharmacy leaders | Lilly drug yields 28.7% weight loss | 20 systems ranked by margins

Vaccine review shifts, specialty expansion & leadership searches continue. December 11, 2025 1. The FDA's new vaccine approval road map, explained Full story 2. FDA panel pushes to reclassify testosterone therapy Full story 3. Radiology pay changes are coming. Get…

FDA expands COVID vaccine review | Healthcare groups reject hep B guidance | ASHP warns of growing drug supply threats | Eli Lilly plans $6B API plant | 1st gene therapy approved for rare syndrome

FDA actions, drug development advances and supply chain threats shape today’s news December 10, 2025 1. FDA expands COVID vaccine death review to include adults Full story 2. FDA approves 1st gene therapy for Wiskott-Aldrich syndrome Full story 3. What's…

FDA to review RSV therapies: Report | USPS delays threaten drug access | Pfizer inks $2B GLP-1 deal | Study supports single-dose HPV vaccine | CVS unveils AI platform

RSV therapy updates, mail-order drug challenges and Pfizer’s $2B deal top today’s news December 9, 2025 1. FDA to reexamine infant RSV therapies Full story 2. Mail-order drug access threatened by USPS delivery slowdowns: Report Full story 3. DSH pressure…

Trump orders vaccine schedule review | 23 drugs in shortage, discontinued | BP drug recalled | Highmark discounts MS, cancer meds | Mirum inks $620M deal for drugmaker

Drug shortages, vaccine policy shifts and drug discounts top today’s news December 8, 2025 1. Trump orders review of international immunization schedules: 3 federal vaccine updates Full story 2. 23 drugs in shortage, discontinued Full story 3. Monitor, detect, protect:…

ISMP flags fatal OR injection risk | FDA taps 2 drug chiefs | 10 systems seeking pharmacy leaders | 5 steps to lift pharmacy to system strategy | Aetna merges Rx, procedures in prior auths

Medication safety alerts, new FDA chiefs & prior auth shifts define the day. December 4, 2025 1. Patient safety groups flag fatal injection risk Full story 2. Aetna merges prescriptions, procedures into single prior authorization Full story 3. This CMIO…

Federal law expands pharmacists' scope | CVS to pay $38M in insulin case | Mount Sinai pharmacy halves prior auth times | FDA clears ranitidine after 5-year recall | Eli Lilly cuts Zepbound price

Scope expansion, faster prior auth & major settlements lead pharmacy headlines. December 3, 2025 1. Law expands pharmacists' role in opioid treatment Full story 2. Mount Sinai's pharmacy goes 'digital-first,' halves prior auth times Full story 3. Creating innovative cardiology care…

FDA reshapes drug policy | AHA sues to halt 340B rebates | WHO issues 1st GLP-1 guideline | US exempts UK-made drugs from tariffs | 14 systems named healthiest workplaces

FDA policy moves, 340B litigation & new GLP-1 guidance shape pharmacy today. December 2, 2025 1. 5 FDA moves reshaping US drug policy Full story 2. AHA sues to block 'unlawful' 340B changes: 4 things to know Full story 3.…